Mark R. Herbert

Medicine · Health Sciences

8h-index949citations31works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(17), Estrogen and related hormone effects(17), Liquid Crystal Research Advancements(5), Chemical Synthesis and Reactions(3), Oxidative Organic Chemistry Reactions(3)

Publications31 total

Supplementary Tables 1-7 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
2023Open Access
Supplementary Figure 3 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
2023Open Access
Supplementary Methods from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
2023Open Access
Supplementary Figure 1 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
2023Open Access
Supplementary Figure 2 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
2023Open Access
Supplementary Figure 2 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
2023Open Access
Supplementary Methods from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
2023Open Access
Supplementary Figure 4 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
2023Open Access
Supplementary Tables 1-7 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
2023Open Access
Supplementary Figure 4 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
2023Open Access
Data from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
2023Open Access
Supplementary Figure 5 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
2023Open Access
Supplementary Figure 5 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
2023Open Access
Data from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
2023Open Access
Supplementary Figure 1 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
2023Open Access
Supplementary Figure 3 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
2023Open Access
ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
Cancer Research·2012· 649 cited
Identification and SAR of selective inducible nitric oxide synthase (iNOS) dimerization inhibitors
Bioorganic & Medicinal Chemistry Letters·2011· 8 citedOpen Access
Synthesis and SAR of 2-aryl-3-aminomethylquinolines as agonists of the bile acid receptor TGR5
Bioorganic & Medicinal Chemistry Letters·2010· 57 citedOpen Access
Inhibition of Inducible Nitric Oxide Synthase Expression by a Novel Small Molecule Activator of the Unfolded Protein Response
Current Chemical Genomics·2008· 6 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Eric D. Bischoff(18), Peter J. Rix(18), Richard A. Heyman(18), Nicola J. Clegg(17), John Wongvipat(17), James D. Joseph(17), Chris Tran(17), Samedy Ouk(17), Yu Chen(17), Kate Grillot(17), Anna Aparicio(17), Steven Dorow(17), Guangbin Yang(17), John Sensintaffar(17), Teresa Wasielewska(17), Céline Bonnefous(17), Beatrice Darimont(17), Howard I. Scher(17), Peter Smith‐Jones(17), Mark Klang(17)